标题
COVID-19 vaccines: The status and perspectives in delivery points of view
作者
关键词
Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immune response, Neutralizing antibodies, Vaccine delivery
出版物
ADVANCED DRUG DELIVERY REVIEWS
Volume 170, Issue -, Pages 1-25
出版商
Elsevier BV
发表日期
2020-12-25
DOI
10.1016/j.addr.2020.12.011
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Positive RT-PCR Test Results in Patients Recovered From COVID-19
- (2020) Lan Lan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
- (2020) Fang Jiang et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Immune Responses to Viral Gene Therapy Vectors
- (2020) Jamie L. Shirley et al. MOLECULAR THERAPY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia
- (2020) Yicheng Fang et al. RADIOLOGY
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
- (2020) Amy S. Espeseth et al. npj Vaccines
- The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
- (2020) Weilong Shang et al. npj Vaccines
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
- (2020) Ahmet Kursat Azkur et al. ALLERGY
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- (2020) Stephen A. Lauer et al. ANNALS OF INTERNAL MEDICINE
- Convalescent plasma in Covid-19: Possible mechanisms of action
- (2020) Manuel Rojas et al. AUTOIMMUNITY REVIEWS
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- An Infectious cDNA Clone of SARS-CoV-2
- (2020) Xuping Xie et al. Cell Host & Microbe
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
- (2020) Hai-qiong Yu et al. EUROPEAN RESPIRATORY JOURNAL
- Treatments in the COVID-19 pandemic: an update on clinical trials
- (2020) Yan Yi Tao et al. EXPERT OPINION ON EMERGING DRUGS
- Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
- (2020) Mona Fani et al. Future Virology
- Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19
- (2020) Hisashi Kai et al. HYPERTENSION RESEARCH
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
- (2020) Manuel Becerra‐Flores et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
- (2020) Wanbing Liu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis
- (2020) Ju Kim et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage
- (2020) Jingyuan Liu et al. Journal of Translational Medicine
- Human leukocyte antigen susceptibility map for SARS-CoV-2
- (2020) Austin Nguyen et al. JOURNAL OF VIROLOGY
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
- (2020) Pedro M Folegatti et al. LANCET INFECTIOUS DISEASES
- Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
- (2020) Tran Thi Nhu Thao et al. NATURE
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
- (2020) Irani Thevarajan et al. NATURE MEDICINE
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
- (2020) Neeltje van Doremalen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS‐CoV‐2 infection‐induced immune responses: friends or foes?
- (2020) Keying Li et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- (2020) Yan Wu et al. SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- Immunomodulation in COVID-19
- (2020) Nicholas E Ingraham et al. Lancet Respiratory Medicine
- Correction: Immunodominant SARS Coronavirus Epitopes in Humans Elicited Both Enhancing and Neutralizing Effects on Infection in Non-human Primates
- (2020) Qidi Wang et al. ACS Infectious Diseases
- Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
- (2020) Angelika Wagner et al. Frontiers in Immunology
- High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice — Skagit County, Washington, March 2020
- (2020) Lea Hamner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
- (2020) Eun Kim et al. EBioMedicine
- The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
- (2020) Xi Wang et al. Cell Discovery
- Progress and Prospects on Vaccine Development against SARS-CoV-2
- (2020) Jinyong Zhang et al. Vaccines
- Nanotechnology for COVID-19: Therapeutics and Vaccine Research
- (2020) Gaurav Chauhan et al. ACS Nano
- Prevalence of Asymptomatic SARS-CoV-2 Infection
- (2020) Daniel P. Oran et al. ANNALS OF INTERNAL MEDICINE
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
- (2020) Lianpan Dai et al. CELL
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
- (2020) Andrea Padoan et al. CLINICA CHIMICA ACTA
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Aerosol Transmission of SARS-CoV-2? Evidence, Prevention and Control
- (2020) Song Tang et al. ENVIRONMENT INTERNATIONAL
- SARS-CoV-2 does not replicate in embryonated hen’s eggs or in MDCK cell lines
- (2020) Ian G Barr et al. Eurosurveillance
- SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
- (2020) Giovanni Salvatori et al. Journal of Translational Medicine
- The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
- (2020) Noton K. Dutta et al. JOURNAL OF VIROLOGY
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
- (2020) Eskild Petersen et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 Vaccine Development: Current Status
- (2020) Gregory A. Poland et al. MAYO CLINIC PROCEEDINGS
- Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
- (2020) Qiangzhe Zhang et al. NANO LETTERS
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- A perspective on potential antibody-dependent enhancement of SARS-CoV-2
- (2020) Ann M. Arvin et al. NATURE
- Next-generation vaccine platforms for COVID-19
- (2020) Debby van Riel et al. NATURE MATERIALS
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Age-dependent effects in the transmission and control of COVID-19 epidemics
- (2020) Nicholas G. Davies et al. NATURE MEDICINE
- Dexamethasone nanomedicines for COVID-19
- (2020) Twan Lammers et al. Nature Nanotechnology
- Immune-mediated approaches against COVID-19
- (2020) Helena F. Florindo et al. Nature Nanotechnology
- COVID-19 vaccine development and a potential nanomaterial path forward
- (2020) Matthew D. Shin et al. Nature Nanotechnology
- Potential neurological effects of severe COVID-19 infection
- (2020) Domenico Nuzzo et al. NEUROSCIENCE RESEARCH
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules
- (2020) Ashish Prasad et al. PLANT CELL REPORTS
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
- (2020) Supriya Ravichandran et al. Science Translational Medicine
- SARS-CoV-2 viral load predicts COVID-19 mortality
- (2020) Elisabet Pujadas et al. Lancet Respiratory Medicine
- Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
- (2020) Sirle Saul et al. ACS Infectious Diseases
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- Leveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
- (2020) Chunxi Zeng et al. ADVANCED MATERIALS
- Monoclonal antibody as a potential anti-COVID-19
- (2020) Leila Jahanshahlu et al. BIOMEDICINE & PHARMACOTHERAPY
- Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy
- (2020) Mahesh Jayaweera et al. ENVIRONMENTAL RESEARCH
- Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
- (2020) Tania Gupta et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Corticosteroids in COVID-19 ARDS
- (2020) Hallie C. Prescott et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
- (2020) Alessandro Gozzetti et al. LEUKEMIA
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health
- (2020) Chelsea N. Fries et al. Nature Nanotechnology
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
- (2020) Eric A. Coomes et al. REVIEWS IN MEDICAL VIROLOGY
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
- (2020) Alfonso Trezza et al. Scientific Reports
- Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
- (2020) Rudra P. Saha et al. Frontiers in Pharmacology
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- A materials-science perspective on tackling COVID-19
- (2020) Zhongmin Tang et al. Nature Reviews Materials
- Natural killer cell immunotypes related to COVID-19 disease severity
- (2020) Christopher Maucourant et al. Science Immunology
- Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
- (2020) Mohammed Osman et al. Blood Advances
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
- (2020) Lizhou Zhang et al. Nature Communications
- Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania
- (2019) Zacchaeus Anywaine et al. JOURNAL OF INFECTIOUS DISEASES
- T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
- (2019) Shane Crotty IMMUNITY
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
- (2019) Liu Vaccines
- Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
- (2019) Brian Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
- (2019) Chean Yeah Yong et al. Frontiers in Microbiology
- Cold chain transportation decision in the vaccine supply chain
- (2019) Qi Lin et al. EUROPEAN JOURNAL OF OPERATIONAL RESEARCH
- Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination
- (2019) Janina M. Jansen et al. JOURNAL OF CLINICAL VIROLOGY
- A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults
- (2019) Morven Wilkie et al. VACCINE
- Engineering dendritic cell vaccines to improve cancer immunotherapy
- (2019) Caleb R. Perez et al. Nature Communications
- Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
- (2019) Thomas Sécher et al. Frontiers in Immunology
- A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice
- (2018) Xiaodan Cai et al. ANTIVIRAL RESEARCH
- Hydroxychloroquine: An old drug with new relevance
- (2018) E. A. SHIPPEY et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research
- (2018) Hanan Al-Lawati et al. Expert Opinion on Drug Delivery
- Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine
- (2018) Dominik Hartl et al. Journal of Innate Immunity
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape
- (2018) Vineet D. Menachery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
- (2018) Mun Peak Nyon et al. VACCINE
- Author Correction: Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
- (2018) Haipeng Liu et al. Scientific Reports
- Development of novel vaccine vectors: Chimpanzee adenoviral vectors
- (2018) Jingao Guo et al. Human Vaccines & Immunotherapeutics
- An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques
- (2018) Yupeng Feng et al. Emerging Microbes & Infections
- Host Immune Response to Influenza A Virus Infection
- (2018) Xiaoyong Chen et al. Frontiers in Immunology
- Synthesis at the interface of virology and genetic code expansion
- (2018) Rachel E Kelemen et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Virus-like particle vaccines: immunology and formulation for clinical translation
- (2018) Braeden Donaldson et al. Expert Review of Vaccines
- DNA Vaccines—How Far From Clinical Use?
- (2018) Dominika Hobernik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Nanoparticle Vaccines Against Infectious Diseases
- (2018) Rashmirekha Pati et al. Frontiers in Immunology
- Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
- (2018) Nataschja I. Ho et al. Frontiers in Immunology
- Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
- (2017) S Guan et al. GENE THERAPY
- Novel viral vectors in infectious diseases
- (2017) Ian R. Humphreys et al. IMMUNOLOGY
- Bacteria isolated from lung modulate asthma susceptibility in mice
- (2017) Aude Remot et al. ISME Journal
- Airway T cells protect against RSV infection in the absence of antibody
- (2017) E Kinnear et al. Mucosal Immunology
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches
- (2017) Nisreen MA Okba et al. Current Opinion in Virology
- Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
- (2017) John J. Suschak et al. Human Vaccines & Immunotherapeutics
- CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function
- (2017) Arata Takeuchi et al. Frontiers in Immunology
- Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
- (2017) Vincent J. Munster et al. npj Vaccines
- Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens
- (2017) Victor Riitho et al. Scientific Reports
- Dendritic cell-based immunotherapy
- (2016) Rachel L Sabado et al. CELL RESEARCH
- The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness
- (2016) Jeroen Luyten et al. HEALTH AFFAIRS
- Tissue-resident dendritic cells and diseases involving dendritic cell malfunction
- (2016) Keqiang Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Materials for non-viral intracellular delivery of messenger RNA therapeutics
- (2016) Kevin J. Kauffman et al. JOURNAL OF CONTROLLED RELEASE
- A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats
- (2016) Christina A. Rostad et al. JOURNAL OF VIROLOGY
- Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung
- (2016) K M Morabito et al. Mucosal Immunology
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Generation of influenza A viruses as live but replication-incompetent virus vaccines
- (2016) L. Si et al. SCIENCE
- Present Yourself! By MHC Class I and MHC Class II Molecules
- (2016) Kenneth L. Rock et al. TRENDS IN IMMUNOLOGY
- A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
- (2016) Wanbo Tai et al. VIROLOGY
- Roles of natural killer cells in antiviral immunity
- (2016) Stephen N Waggoner et al. Current Opinion in Virology
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3
- (2016) Pak-Yin Lui et al. Emerging Microbes & Infections
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
- (2015) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Systematic Identification of Factors for Provirus Silencing in Embryonic Stem Cells
- (2015) Bin Xia Yang et al. CELL
- Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
- (2015) Naru Zhang et al. Cellular & Molecular Immunology
- The innate immune function of airway epithelial cells in inflammatory lung disease
- (2015) Pieter S. Hiemstra et al. EUROPEAN RESPIRATORY JOURNAL
- Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production
- (2015) Sean R. McMaster et al. JOURNAL OF IMMUNOLOGY
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- The emerging role of resident memory T cells in protective immunity and inflammatory disease
- (2015) Chang Ook Park et al. NATURE MEDICINE
- Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine
- (2015) Jose M. Jimenez-Guardeño et al. PLoS Pathogens
- In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
- (2015) Oscar E. Simonson et al. Stem Cells Translational Medicine
- Interferon-Stimulated Genes: A Complex Web of Host Defenses
- (2014) William M. Schneider et al. Annual Review of Immunology
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma-Homing CD4 T Cells
- (2014) S. Sakai et al. JOURNAL OF IMMUNOLOGY
- Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
- (2014) N. Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
- (2014) R. Channappanavar et al. JOURNAL OF VIROLOGY
- Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4
- (2014) N. van Doremalen et al. JOURNAL OF VIROLOGY
- The contribution of vaccination to global health: past, present and future
- (2014) B. Greenwood PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
- (2014) Jiaming Lan et al. PLoS One
- History of vaccination
- (2014) S. Plotkin PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study
- (2014) Guoping Zheng et al. RESPIRATORY RESEARCH
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- How advances in immunology provide insight into improving vaccine efficacy
- (2014) Mark K. Slifka et al. VACCINE
- Mucosal Resident Memory CD4 T Cells in Protection and Immunopathology
- (2014) Damian Lanz Turner et al. Frontiers in Immunology
- Differential Roles of Lung Dendritic Cell Subsets Against Respiratory Virus Infection
- (2014) Tae Hoon Kim et al. Immune Network
- Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection
- (2013) Qiang Liu et al. ACTA PHARMACOLOGICA SINICA
- Virus-like particles for the prevention of human papillomavirus-associated malignancies
- (2013) Joshua W Wang et al. Expert Review of Vaccines
- Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease
- (2013) X. Yang et al. JOURNAL OF GENERAL VIROLOGY
- Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein
- (2013) C. Fett et al. JOURNAL OF VIROLOGY
- Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
- (2013) D. Niemeyer et al. JOURNAL OF VIROLOGY
- Lung niches for the generation and maintenance of tissue-resident memory T cells
- (2013) D L Turner et al. Mucosal Immunology
- Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer
- (2013) Anne Flörcken et al. Human Vaccines & Immunotherapeutics
- Dendritic cell-based vaccines: barriers and opportunities
- (2012) Jessica A Cintolo et al. Future Oncology
- Cellular immune reactions in the lung
- (2012) Mike Hasenberg et al. IMMUNOLOGICAL REVIEWS
- Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity
- (2012) Xiaodong Jiang et al. NATURE
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
- (2012) Daniel X. Johansson et al. PLoS One
- Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Artificial Molecular Clamp: A Novel Device for Synthetic Polymerases
- (2011) Yoshinori Takashima et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection
- (2011) J. R. Teijaro et al. JOURNAL OF IMMUNOLOGY
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Therapeutic siRNA silencing in inflammatory monocytes in mice
- (2011) Florian Leuschner et al. NATURE BIOTECHNOLOGY
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848
- (2011) Kai Zhao et al. VACCINE
- Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis
- (2011) Marie Ballester et al. VACCINE
- Lopinavir/Ritonavir
- (2010) Jamie D. Croxtall et al. DRUGS
- Overview of the immune response
- (2010) David D. Chaplin JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as a Dominant Immunogen Revealed by a Clustering Region of Novel Functionally and Structurally Defined Cytotoxic T‐Lymphocyte Epitopes
- (2010) Jun Liu et al. JOURNAL OF INFECTIOUS DISEASES
- Rationalizing the development of live attenuated virus vaccines
- (2010) Adam S Lauring et al. NATURE BIOTECHNOLOGY
- Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza
- (2010) André Ballesteros-Tato et al. NATURE IMMUNOLOGY
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection
- (2009) J. Chen et al. JOURNAL OF VIROLOGY
- Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF- B Signaling
- (2009) M. Frieman et al. JOURNAL OF VIROLOGY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Challenges in the development of an HIV-1 vaccine
- (2008) Dan H. Barouch NATURE
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
- Basic science of the innate immune system and the lung
- (2008) Nazia Chaudhuri et al. Paediatric Respiratory Reviews
- Effects of Different Immunization Protocols and Adjuvant on Antibody Responses to Inactivated SARS-CoV Vaccine
- (2008) Weiwei Gai et al. VIRAL IMMUNOLOGY
- SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum
- (2008) Kèvin Knoops et al. PLOS BIOLOGY
- Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
- (2007) Luis Enjuanes et al. VIRUS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started